Developer docs
API playgroundTry for free, no card

Search company profiles

JONSSON CANCER CENTER FOUNDATION/UCLA

Full company profile

uuid0042tsf

Namestring
JONSSON CANCER CENTER FOUNDATION/UCLA
Legal namestring
UCLA Jonsson Cancer Center Foundation
Websiteurl
cancer.ucla.edu
Company typeenum
Public
Founded yearint
1976
Descriptiontext

The UCLA Health Jonsson Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center and a component of UCLA Health within the University of California system, operating as a public state-government entity rather than a privately held or traded company. Founded circa 1976, it runs an integrated platform combining clinical cancer services, translational research programs, SPORE-funded specialized research, and shared research infrastructure (including flow cytometry and related laboratory resources) across 15 cancer types. Its core offering comprises prevention, diagnosis, precision treatment, survivorship support, and clinical trial enrollment, delivered through the flagship Los Angeles academic medical center and 24 community clinic locations across Southern California.

The center is staffed by 500+ physicians, scientists and engineers working in tandem to move discoveries from the lab to the clinic, supported by an Office of Cancer Training & Education and a Translational Research Symposium Series. Revenue is generated through three streams: clinical care services billed through UCLA Health, philanthropy collected via the Jonsson Cancer Center Foundation (operating under the legal name "UCLA Jonsson Cancer Center Foundation" via channels including GiveButter), and research grants including NIH SPORE awards and institutional RAU funding. Specific pricing is not publicly disclosed; patient access follows standard academic-medical-center insurance verification, financial counseling, and physician-referral pathways.

The entity maintains NCCN member status, partnership with The Lancet Commission on Cancer and Health Systems, and consistent U.S. News & World Report top-cancer-center recognition. It is HIPAA-compliant, serves as a Veterans Health Administration research collaborator, and operates within the University of California's consolidated public reporting framework, so individual revenue figures are not publicly disclosed.

Short descriptiontext

The UCLA Health Jonsson Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center providing research-driven cancer care — prevention, diagnosis, precision treatment, survivorship support, and clinical trials across 15 cancer types — to patients across Southern California through 24 community clinic locations and the flagship Los Angeles campus, supported by 500+ physicians, scientists, and engineers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices24 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer treatment services, clinical research oncology, academic cancer center, precision medicine oncology, cancer clinical trials
Industry7 codes
1Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryYes
2Hospital-Integrated Cancer Centers (Acute Oncology Programs)
CodeHLAFAAAMPrimaryNo
3Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryNo
4Thoracic (Lung) Oncology
CodeHLAKAFALPrimaryNo
5Gynecologic Oncology & Women’s Cancer Centers
CodeHLAFAJAKPrimaryNo
6Women’s Imaging & Breast Health Centers
CodeHLAFAJAJPrimaryNo
7Public Research Universities with Academic Medical Centers (AMCs)
CodeEDAHAAACPrimaryNo
NAICS code3 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • Specialty (except Psychiatric and Substance Abuse) Hospitals6223
  • Offices of Physicians62111
SIC code2 codes
  • Services-Hospitals8060
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Academic Cancer Center Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Care Services
TypeSubscription Recurring
Description

Revenue generated from comprehensive cancer treatment services including prevention, diagnosis, precision treatments, and survivorship support provided to patients across Southern California locations

uclahealth.org
2Philanthropy and Donations
TypeSubscription Recurring
Description

The Jonsson Cancer Center Foundation raises funds through donations to support groundbreaking cancer research, expand access to care, and accelerate lifesaving discoveries

uclahealth.org
3Research Grants and Funding
TypeLicensing Royalties
Description

Federal and institutional research funding including SPORE grants, career development awards, and RAU funding opportunities for researchers

uclahealth.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

The UCLA Health Jonsson Comprehensive Cancer Center is an academic cancer center that delivers comprehensive cancer care including prevention, diagnosis, precision treatments, survivorship support, and clinical trials, supported by translational research programs. It operates across more than 20 locations in Southern California, staffed by 500+ physicians, scientists, and engineers who translate laboratory discoveries into personalized patient treatments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 50 years of continuous operation as a comprehensive cancer center
+1 more record
Product overview1 text field

UCLA Health Jonsson Comprehensive Cancer Center is a single unified healthcare offering that combines research, innovation, and clinical excellence to deliver comprehensive cancer care. The center operates as an integrated platform consisting of core clinical services (Cancer Services), clinical research programs, research programs, and shared resources for researchers. Supporting modules include Find a Specialist, Find a Location, Cancer Patient Programs & Resources, and Get a Second Opinion services. The center serves patients across Southern California with 500+ physicians, scientists and engineers working side-by-side to deliver breakthrough discoveries and proven treatments, offering clinical trials across 15 cancer types at UCLA and community clinic locations.

Product and service6 records
1Cancer Services
CategoryClinical Care
2Cancer Clinical Trials
CategoryClinical Research
3Clinical Research
CategoryClinical Research
4Research Programs
CategoryResearch
5Get a Second Opinion
CategoryClinical Care
6Cancer Patient Programs and Resources
CategoryPatient Support Services
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

As an NCCN member institution, the Jonsson Comprehensive Cancer Center adheres to NCCN Guidelines for cancer treatment, participates in the development of evidence-based standards for cancer care, and collaborates with other leading cancer centers to advance the quality and effectiveness of cancer treatment nationwide.

2SPOREs (Specialized Programs of Research Excellence)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NIH-funded specialized research programs focused on specific cancer types. The cancer center maintains SPORE grants that fund translational research to improve prevention, detection, diagnosis, and treatment of cancer.

uclahealth.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Los Angeles-based academic cancer program providing comprehensive cancer care and clinical research in the same Southern California market. Comparable as a regional specialty oncology competitor drawing from overlapping patient populations.

TypeDirect peer
Description

Southern California-based NCI-designated Comprehensive Cancer Center with clinical care, translational research, and clinical trials. Direct regional peer with overlapping patient catchment and similar academic mission.

TypeDirect peer
Description

University of Texas-affiliated NCI-designated Comprehensive Cancer Center consistently ranked #1 in U.S. News. Direct comparable in scale of research programs, clinical trials portfolio, and specialty cancer care delivery.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center in New York with similar translational research, clinical trials, and specialty oncology care across multiple cancer types. Direct comparable as one of the leading academic oncology centers in the U.S.

TypeDirect peer
Description

Seattle-based NCI-designated Comprehensive Cancer Center affiliated with University of Washington. Direct comparable in translational research scale, clinical trials portfolio, and academic cancer care delivery model.

TypeDirect peer
Description

Harvard-affiliated NCI-designated Comprehensive Cancer Center with deep translational research programs and clinical trials across cancer types. Closely comparable as a top-ranked research-driven oncology specialty provider.

TypeDirect peer
Description

USC Keck School of Medicine's NCI-designated Comprehensive Cancer Center also based in Los Angeles. Closest in-region peer competing for the same patient population, faculty, and philanthropy in the LA market.

TypeBroad incumbent
Description

Mayo Clinic's NCI-designated cancer center providing comprehensive cancer care across multiple sites. Broader incumbent in academic specialty oncology with national referral patterns and integrated multispecialty delivery model.

TypeDirect peer
Description

UC San Francisco's NCI-designated Comprehensive Cancer Center within the University of California system. Comparable as a UC system peer with similar research funding profile, clinical trial portfolio, and academic mission.

TypeDirect peer
Description

Stanford University's NCI-designated cancer center with translational research programs and clinical trials across cancer types. Comparable as a top-tier academic oncology center in California with elite research capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

JONSSON CANCER CENTER FOUNDATION/UCLA

Academic Cancer Center Servicescancer.ucla.edu

The UCLA Health Jonsson Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center providing research-driven cancer care — prevention, diagnosis, precision treatment, survivorship support, and clinical trials across 15 cancer types — to patients across Southern California through 24 community clinic locations and the flagship Los Angeles campus, supported by 500+ physicians, scientists, and engineers.

What JONSSON CANCER CENTER FOUNDATION/UCLA does

The UCLA Health Jonsson Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center and a component of UCLA Health within the University of California system, operating as a public state-government entity rather than a privately held or traded company. Founded circa 1976, it runs an integrated platform combining clinical cancer services, translational research programs, SPORE-funded specialized research, and shared research infrastructure (including flow cytometry and related laboratory resources) across 15 cancer types. Its core offering comprises prevention, diagnosis, precision treatment, survivorship support, and clinical trial enrollment, delivered through the flagship Los Angeles academic medical center and 24 community clinic locations across Southern California.

The center is staffed by 500+ physicians, scientists and engineers working in tandem to move discoveries from the lab to the clinic, supported by an Office of Cancer Training & Education and a Translational Research Symposium Series. Revenue is generated through three streams: clinical care services billed through UCLA Health, philanthropy collected via the Jonsson Cancer Center Foundation (operating under the legal name "UCLA Jonsson Cancer Center Foundation" via channels including GiveButter), and research grants including NIH SPORE awards and institutional RAU funding. Specific pricing is not publicly disclosed; patient access follows standard academic-medical-center insurance verification, financial counseling, and physician-referral pathways.

The entity maintains NCCN member status, partnership with The Lancet Commission on Cancer and Health Systems, and consistent U.S. News & World Report top-cancer-center recognition. It is HIPAA-compliant, serves as a Veterans Health Administration research collaborator, and operates within the University of California's consolidated public reporting framework, so individual revenue figures are not publicly disclosed.

JONSSON CANCER CENTER FOUNDATION/UCLA firmographics

Firmographics
Name
JONSSON CANCER CENTER FOUNDATION/UCLA
Legal name
UCLA Jonsson Cancer Center Foundation
Website
https://cancer.ucla.edu
Company type
Public
Founded year
1976
Operating status
Operating
Headcount range
1–10 employees
Short description
The UCLA Health Jonsson Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center providing research-driven cancer care — prevention, diagnosis, precision treatment, survivorship support, and clinical trials across 15 cancer types — to patients across Southern California through 24 community clinic locations and the flagship Los Angeles campus, supported by 500+ physicians, scientists, and engineers.
Ownership category
akta.pro rank

JONSSON CANCER CENTER FOUNDATION/UCLA industry classification

Industry
Product category
Academic Cancer Center Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Offices of Physicians (62111)
SIC
Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Oncology & Cancer Specialty Hospitals (HLAFAHAC)
akta.pro secondary industries
Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Thoracic (Lung) Oncology (HLAKAFAL), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK), Women’s Imaging & Breast Health Centers (HLAFAJAJ), Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)

Keywords

  • Cancer treatment services
  • Clinical research oncology
  • Academic cancer center
  • Precision medicine oncology
  • Cancer clinical trials

Where JONSSON CANCER CENTER FOUNDATION/UCLA is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices24 records

Markets served

JONSSON CANCER CENTER FOUNDATION/UCLA business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Clinical Care Services: Revenue generated from comprehensive cancer treatment services including prevention, diagnosis, precision treatments, and survivorship support provided to patients across Southern California locations
  2. Philanthropy and Donations: The Jonsson Cancer Center Foundation raises funds through donations to support groundbreaking cancer research, expand access to care, and accelerate lifesaving discoveries
  3. Research Grants and Funding: Federal and institutional research funding including SPORE grants, career development awards, and RAU funding opportunities for researchers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

JONSSON CANCER CENTER FOUNDATION/UCLA product offering

Product offering

Core offering

The UCLA Health Jonsson Comprehensive Cancer Center is an academic cancer center that delivers comprehensive cancer care including prevention, diagnosis, precision treatments, survivorship support, and clinical trials, supported by translational research programs. It operates across more than 20 locations in Southern California, staffed by 500+ physicians, scientists, and engineers who translate laboratory discoveries into personalized patient treatments.

Product overview

UCLA Health Jonsson Comprehensive Cancer Center is a single unified healthcare offering that combines research, innovation, and clinical excellence to deliver comprehensive cancer care. The center operates as an integrated platform consisting of core clinical services (Cancer Services), clinical research programs, research programs, and shared resources for researchers. Supporting modules include Find a Specialist, Find a Location, Cancer Patient Programs & Resources, and Get a Second Opinion services. The center serves patients across Southern California with 500+ physicians, scientists and engineers working side-by-side to deliver breakthrough discoveries and proven treatments, offering clinical trials across 15 cancer types at UCLA and community clinic locations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cancer Services
  • Cancer Clinical Trials
  • Clinical Research
  • Research Programs
  • Get a Second Opinion
  • Cancer Patient Programs and Resources

Quantifiable outcome

  • 50 years of continuous operation as a comprehensive cancer center
  • +1 more outcomes

Companies that use JONSSON CANCER CENTER FOUNDATION/UCLA

Customer profile

Named customers2 records

Segments5 records

Ideal customer profiles3 records

JONSSON CANCER CENTER FOUNDATION/UCLA technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

JONSSON CANCER CENTER FOUNDATION/UCLA partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • National Comprehensive Cancer Network (NCCN)coreStrategic or Co-development PartnerAs an NCCN member institution, the Jonsson Comprehensive Cancer Center adheres to NCCN Guidelines for cancer treatment, participates in the development of evidence-based standards for cancer care, and collaborates with other leading cancer centers to advance the quality and effectiveness of cancer treatment nationwide.
  • SPOREs (Specialized Programs of Research Excellence)coreStrategic or Co-development PartnerNIH-funded specialized research programs focused on specific cancer types. The cancer center maintains SPORE grants that fund translational research to improve prevention, detection, diagnosis, and treatment of cancer.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

JONSSON CANCER CENTER FOUNDATION/UCLA competitors and assessment

Company assessment

Regional players

  • Cedars-Sinai Cancer: Los Angeles-based academic cancer program providing comprehensive cancer care and clinical research in the same Southern California market. Comparable as a regional specialty oncology competitor drawing from overlapping patient populations.

Direct peers

  • City of Hope Comprehensive Cancer Center: Southern California-based NCI-designated Comprehensive Cancer Center with clinical care, translational research, and clinical trials. Direct regional peer with overlapping patient catchment and similar academic mission.
  • MD Anderson Cancer Center: University of Texas-affiliated NCI-designated Comprehensive Cancer Center consistently ranked #1 in U.S. News. Direct comparable in scale of research programs, clinical trials portfolio, and specialty cancer care delivery.
  • Memorial Sloan Kettering Cancer Center: NCI-designated Comprehensive Cancer Center in New York with similar translational research, clinical trials, and specialty oncology care across multiple cancer types. Direct comparable as one of the leading academic oncology centers in the U.S.
  • Fred Hutchinson Cancer Center: Seattle-based NCI-designated Comprehensive Cancer Center affiliated with University of Washington. Direct comparable in translational research scale, clinical trials portfolio, and academic cancer care delivery model.
  • Dana-Farber Cancer Institute: Harvard-affiliated NCI-designated Comprehensive Cancer Center with deep translational research programs and clinical trials across cancer types. Closely comparable as a top-ranked research-driven oncology specialty provider.
  • USC Norris Comprehensive Cancer Center: USC Keck School of Medicine's NCI-designated Comprehensive Cancer Center also based in Los Angeles. Closest in-region peer competing for the same patient population, faculty, and philanthropy in the LA market.
  • UCSF Helen Diller Family Comprehensive Cancer Center: UC San Francisco's NCI-designated Comprehensive Cancer Center within the University of California system. Comparable as a UC system peer with similar research funding profile, clinical trial portfolio, and academic mission.
  • Stanford Cancer Institute: Stanford University's NCI-designated cancer center with translational research programs and clinical trials across cancer types. Comparable as a top-tier academic oncology center in California with elite research capabilities.

Broad incumbents

  • Mayo Clinic Comprehensive Cancer Center: Mayo Clinic's NCI-designated cancer center providing comprehensive cancer care across multiple sites. Broader incumbent in academic specialty oncology with national referral patterns and integrated multispecialty delivery model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

JONSSON CANCER CENTER FOUNDATION/UCLA social profiles

Digital presence

JONSSON CANCER CENTER FOUNDATION/UCLA compliance and trust

Trust signal

Compliance1 record

JONSSON CANCER CENTER FOUNDATION/UCLA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

JONSSON CANCER CENTER FOUNDATION/UCLA leadership team

Management profile

Number of profiles

JONSSON CANCER CENTER FOUNDATION/UCLA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

JONSSON CANCER CENTER FOUNDATION/UCLA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JONSSON CANCER CENTER FOUNDATION/UCLA

What does JONSSON CANCER CENTER FOUNDATION/UCLA do?

The UCLA Health Jonsson Comprehensive Cancer Center is an academic cancer center that delivers comprehensive cancer care including prevention, diagnosis, precision treatments, survivorship support, and clinical trials, supported by translational research programs. It operates across more than 20 locations in Southern California, staffed by 500+ physicians, scientists, and engineers who translate laboratory discoveries into personalized patient treatments.

Is JONSSON CANCER CENTER FOUNDATION/UCLA a public or private company?

JONSSON CANCER CENTER FOUNDATION/UCLA is a public company. It is classified as state government owned and is currently operating.

When was JONSSON CANCER CENTER FOUNDATION/UCLA founded?

JONSSON CANCER CENTER FOUNDATION/UCLA was founded in 1976. It employs 1 to 10 people.

Where is JONSSON CANCER CENTER FOUNDATION/UCLA based?

JONSSON CANCER CENTER FOUNDATION/UCLA is headquartered in Los Angeles, United States, in the North America region.

How does JONSSON CANCER CENTER FOUNDATION/UCLA make money?

Three revenue lines are on record. Clinical Care Services are the primary driver. The others are philanthropy and Donations and research Grants and Funding.

Who are JONSSON CANCER CENTER FOUNDATION/UCLA's main competitors?

Cedars-Sinai Cancer is listed as a regional player. Direct peers are City of Hope Comprehensive Cancer Center, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Fred Hutchinson Cancer Center, Dana-Farber Cancer Institute, USC Norris Comprehensive Cancer Center, UCSF Helen Diller Family Comprehensive Cancer Center and Stanford Cancer Institute. Mayo Clinic Comprehensive Cancer Center is listed as a broad incumbent.

Does JONSSON CANCER CENTER FOUNDATION/UCLA have an API?

No public API is recorded for JONSSON CANCER CENTER FOUNDATION/UCLA.

What industry is JONSSON CANCER CENTER FOUNDATION/UCLA in?

JONSSON CANCER CENTER FOUNDATION/UCLA's product category is Academic Cancer Center Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs). Its NAICS code is 622310 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mirage NewsTraditional Risk Factors Fail in Hormone Therapy PredictionA study led by UCLA Health Jonsson Comprehensive Cancer Center researchers analyzed 4,781 prostate cancer patients across five phase 3 clinical trials and found that traditional pathological features used to classify aggressive prostate cancer do not predict which patients will benefit from adding hormone therapy to postoperative radiation. The researchers confirmed that while patients with more adverse pathological features had worse outcomes overall, the number of adverse features did not influence the benefit of adding hormone therapy for overall survival or metastasis-free survival. The findings highlight the need for molecular biomarkers that can better predict treatment response and enable more personalized treatment approaches.UCLA HealthUCLA Health launches novel clinical trial for recurrent prostate cancerUCLA Health Jonsson Comprehensive Cancer Center has launched the ANDROMEDA Phase 2 clinical trial to test whether combining two types of PSMA-targeted radiopharmaceutical therapies with stereotactic body radiotherapy can effectively treat recurrent prostate cancer while delaying or avoiding long-term hormone therapy. The trial will directly compare lutetium-177–PSMA-617 and actinium-225–PSMA-617 in men with oligorecurrent prostate cancer, building on earlier research including the LUNAR trial that showed encouraging early results. Researchers hope this combination approach can eliminate both visible tumors and microscopic disease while preserving patient quality of life.GlobeNewswireNew research in ONCOLOGY® identifies gaps between gynecologic cancer disease burden and clinical trial availability at UCLA Jonsson Comprehensive Cancer CenterA UCLA Jonsson Comprehensive Cancer Center study found clinical trial availability for ovarian, uterine, and cervical cancers did not match local disease incidence. Ovarian cancer trials accounted for 67% of available studies despite representing only 25% of cases, while uterine cancer trials were 21% of studies versus 59% of cases. The authors call for increased government funding and industry investment to address disparities.BioengineeringUCLA Receives NIH Grant to Cultivate Future Leaders in Brain CancerThe NIH awarded UCLA Health Jonsson Comprehensive Cancer Center a $1.72 million grant to establish a five-year Neuro-Oncology Translational Research Training Program designed to bridge laboratory research and clinical applications in brain cancer treatment. The program will support predoctoral and postdoctoral researchers and clinical fellows, with a focus on glioblastoma and brain metastases, under the leadership of Dr. Robert Prins and Dr. Benjamin Ellingson. Applications for the program are set to open in spring, aiming to cultivate the next generation of brain tumor scientists and physician-scientists.GlobeNewswireCancerVAX CEO Ryan Davies Discusses the Company’s Growing Pipeline of Cancer TreatmentsCancerVAX CEO Ryan Davies discussed the company's growing pipeline of cancer treatments developed with UCLA, including three platforms: Ewing sarcoma immunotherapy, a universal cancer vaccine, and a universal CAR-T cell platform. He noted CAR-T therapies cost about $500,000 per dose and aims to reduce costs to thousands of dollars.PR NewswireNational Comprehensive Cancer Network Announces Addition of UCLA Jonsson Comprehensive Cancer Center and UT Southwestern Simmons Comprehensive Cancer CenterThe National Comprehensive Cancer Network announced the addition of UCLA Jonsson Comprehensive Cancer Center and UT Southwestern Simmons Comprehensive Cancer Center as its 29th and 30th member institutions, expanding its alliance to 30 leading academic cancer centers. Both new members, located in Los Angeles and Dallas respectively, will contribute experts to develop and update NCCN's Clinical Practice Guidelines—the standard for evidence-based cancer care covering 97 percent of cancers affecting U.S. patients. The announcement comes as NCCN celebrates its 25th anniversary year, having grown from 13 founding centers in 1995.GlobeNewswireOngoing Trial May Lead to Better Understanding of Oral Mucositis, a Debilitating Side Effect Affecting Many Cancer PatientsAn ongoing clinical trial at UCLA's Jonsson Comprehensive Cancer Center is evaluating MuGard, an oral wound rinse, for managing oral mucositis in breast cancer patients. The trial uses everolimus, which can cause severe stomatitis, and MuGard coats mucosal tissue to protect against sores. Oral mucositis affects up to 40% of chemotherapy patients and 97% of head-and-neck radiation patients.